NCT05372718View on ClinicalTrials.gov

Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

December 26, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Limb Ischemia
Interventions
DRUG

Recombinant non-immunogenic staphylokinase (Fortelyzin®)

lyophilisate for preparation a solution

PROCEDURE

surgical methods of treatment

Endovascular intervention, open surgery and/or bypass surgery in accordance with the current National Guidelines

Trial Locations (5)

115446

RECRUITING

S.S. Yudin City clinical hospital, Moscow

125284

RECRUITING

S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow

141301

RECRUITING

Sergiyev Posad Regional Clinical Hospital, Sergiyev Posad

305035

RECRUITING

Kursk city emergency hospital, Kursk

400138

RECRUITING

Volgograd City Clinical Hospital of Emergency #25, Volgograd

All Listed Sponsors
lead

Supergene, LLC

INDUSTRY